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SUMMARY
Background: The interesting feature of childhood asthma is the great reversibility of symptoms. The main pur-
pose of this study was to assess the effect of persistent and reversed asthma-like symptoms on lung function
growth in preadolescent children.
Material and methods: The follow-up respiratory health survey has been conducted in the sample of 1129 chil-
dren aged 9 yrs over two years follow-up. The basic health end-points was the occurrence of asthma-like symp-
toms and the slower lung function growth (SLFG).
Results: Adjusted OR for SLFG(FVC) was significantly higher only in the children having the continued symp-
toms(OR=3.40; 95%CI: 1.32—8.77). There was a consistent trend of adjusted ORs for SLFG(FEV1) with the
category of symptoms, where OR was 1.46 (95%CI:1.02—2.10) in children with recent new symptoms; 2.06;
(95%CI: 0.93—4.58) in those with symptoms remitted, while 3.46; (95% CI: 1.43—8.40) in children who had
persistent symptoms. The corresponding ORs for SLFG(FEF25-75%) were 2.03; (95%CI: 0.97—4.28), 2.63;
(95% CI: 1.38—4.99), and 5.84; (95%CI: 2.53—13.50).
Conclusions: The consistent association between reversibility of asthma-like symptoms and lung function gain
in preadolescent children confirmed the clinical significance of the symptoms in question. The observed slower
lung function gain in preadolescence may have implications for the development of chronic lung disease later in
adulthood.
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BACKGROUND
Asthma primarily is a disease in children among
whom its prevalence and rate of hospitalisation ha-
ve increased over the past 20 years [1,2]. About 30
percent of all asthmatics are under the age of 18,
and half of all these asthma cases are diagnosed by
age 5. The interesting feature of childhood asthma
is the great reversibility of symptoms since roughly
half of all childhood asthmatics will have their
symptoms remit by early adulthood [3].
It is under debate to which extent occasional and
recent wheezing may lead to change in lung func-
tion in infants and children, although these chan-
ges may be within normal values of spirometric re-
ference values. Clinical or cross-sectional studies in
children have already indicated that persistent
wheeze is associated with reduced pulmonary
function [4], but it is not clear whether recent
symptoms have also the same impact and whether
the symptoms are associated with the lung growth
in the preadolescent children. To date the effect of
change in wheezing symptoms in terms of lung
growth in children has have been explored only in
a few studies [5—7]. Interpretation of pulmonary
function growth in children in terms of the occur-
rence of asthmatic symptoms is not an easy task
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because it varies strongly with a childÕs stage of
growth. Cross-sectional analyses have shown that
a childÕs pulmonary function increases linearly with
age and height until the adolescent growth spurt,
which occurs at approximately 10 years of age in
girls and 12 years of age in boys [7—10]. Considera-
ble individual variations in the onset or magnitude
of the adolescent height growth spurt and lung
function development have been reported in
a number of studies [11—15].
The main purpose of this study was to measure the
occurrence of asthma-like symptoms over two year
period in preadolescent children, and to assess the
effect of recent and persistent asthma-like symp-
toms on lung function growth over two year fol-
low-up. In addition, the effect of symptoms that re-
versed over two-year period was assessed as well.
MATERIAL AND METHODS
The epidemiologic cohort study was conducted in
Krakow, a city with approximately 700,000 inhabi-
tants in Southern Poland. The children from the
twelve grammar schools located in the city centre
and in the peripheral part of the city have been
chosen. The details on the study sample is provi-
ded elsewhere [16]. In the chosen schools a full list
of students with their residence addresses were
prepared, and consequently, parents of all 1165
children attending the second form (9 years of age)
of the selected schools were contacted. Out of all
1129 eligible parents, 97% of them agreed to be
interviewed on the respiratory health of their chil-
dren and household characteristics.
The baseline field health survey was performed in
1995 and the annual follow-up has been conduc-
ted over subsequent two years (1996—1997). He-
alth assessment has been based on standardized
interviews, anthropometry and spirometric measu-
rements. The health questionnaire contained qu-
estions on respiratory symptoms recommended by
the Epidemiology Standardisation Project and ATS
[17].
The basic health end-point for the respiratory
symptoms was asthma-like syndrome defined as
the occurrence of wheezing and/or attacks of bre-
athlessness. Interviewers instructed the parents that
by wheeze sounds we understood whistling in the
chest, independent of colds or fever and by attacks
of breathlessness the dyspnea attacks accompanied
by wheezing or whistling.
Symptoms were assessed separately in each annual
survey as present(+) or absent(-), and the subjects
were classified in four categories according to the
pattern of the symptoms reported. Classification of
the children in respect to the occurrence of asth-
matic syndrome based on the follow-up was follo-
wing:
1. Healthy: a syndrome never present; before
1995 and in the period 1995-1997; (— — —)
2. New cases: a syndrome absent in 1995 but pre-
sent in 1996 or 1997; (— — +) or (— + +) or (— +
—),
3. Continued: a syndrome present at least in two
surveys; (+ + +) or (+ + —) or (+ — +),
4. Remission: a syndrome present in 1995 but not
in 1997; (+ — —).
Spirometric measurements were carried out with
computerized Vitalograph Spirotrac III portable spi-
rometer where the measurement of air flow from
the subject is made using a Fleisch type pneumo-
tach. The spirometric testing has been done only in
the standing position. The spirometer program has
chosen the best flow out of three blows executed
by each child. The lung function testing included
the following indices: FVC, FEV1 and FEF25-75%.
Each day, prior to the lung function examination,
the spirometer was checked with one-liter syringe
and 3% variablity was acceptable. One trained
technician in all health surveys has performed all
spirometric testing.
For the purpose of the analysis lung function
growth measured over the follow-up has been divi-
ded in five categories using quintiles of lung func-
tion gain in two years. The main spirometric end
point variable of the effects under study was the
slower lung function growth (SLFG) over two year
period, which was defined whether or not the gain
over two years was within the lowest quintile of
the distribution of a given spirometric test.
Assessment of body growth (height velocity) was
based on the measurements of the standing height
of children in cm over two year period. Standing
height is assumed to be the single most important
determinant of pulmonary function growth and he-
ight velocity is a reliable index of the onset of pu-
berty during adolescence. For the purpose of the
statistical analysis, the children have been classified
in three categories by their growth rate (1. the fast
growth rate: 14 cm and more in two years; 2. me-
dium growth rate: 10—13 cm; and 3. slow growth
rate: 9 cm or less).
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As the first step in the analysis of data, we have
carried out the univariate descriptive statistics of
pulmonary function indices by categories of asth-
ma symptoms and SLFG for each of the spirometric
tests has been established. Subsequently, multiva-
riate linear regression analysis has been used for
choosing body variables being significant predictors
of the pulmonary growth. Variables that were asso-
ciated with pulmonary function in this analysis inc-
luded baseline height and the baseline of a given
pulmonary test, growth rate (difference in height
between 1997 and 1995) and gender. In the se-
cond stage of the analysis, we used multivariate lo-
gistic regression (MLR) to calculate the odds ratio
for the SLFG and asthma symptoms together with
predictors of lung function growth and other po-
tential confounders [18]. Descriptive and multiva-
riate analysis were done with BMDP programs
[19].
RESULTS
In the total study sample, there was 45 children
with the new symptoms, 54 with symptoms remit-
ted and 30 with continued symptoms (table 1).
The children with new symptoms and with conti-
nued symptoms more frequently came from the fa-
milies with lower parental education; the propor-
tion of boys have been greater in those who had
continued symptoms.
Mean crude spirometric gain (the difference
1997—1995) for FVC and FEV1 over two-year fol-
low up was smaller in children with continued or
remitted symptoms when compared with children
without symptoms or with the recent ones. Also
the gain in FEF25-75% was smaller in those subjects
who reported continued symptoms. Interestingly,
the children with continued symptoms had smaller
gain in height but greater gain in weight over the
follow-up period.
The slower lung function growth (SLFG) was found
more often in children who presented the symp-
Predictors
SLFG
(+) (—)
N
Crude OR
(95% CI)
Adjusted OR
(95% CI)
FVC
Without symptoms
New symptoms
Remitted symptoms
Continued symptoms
FEV1
Without symptoms
New symptoms
Remitted symptoms
Continued symptoms
FEF25-75%
Without symptoms
New symptoms
Remitted symptoms
Continued symptoms
SLFGFVC(+) £0.23 L, SLFGFEV1(+) £0.18 L,
SLFGFEF25-75%(+) without lung function gain.
168
9
11
12
176
12
16
12
172
13
18
15
704
36
43 
18
696 
33
38 
18
700 
32
36 
15
1.00
1.05 (0.46—2.36)
1.07 (0.51—2.21)
2.79 (1.24—6.24)
1.00
1.44 (0.69—2.96)
1.67 (0.87—3.17)
2.64 (1.17—5.88)
1.00
1.65 (0.80—3.35)
2.03 (1.08—3.80)
4.07 (1.84—8.98)
1.00
1.25 (0.52—2.97)
1.11 (0.51—2.21)
3.40 (1.32—8.77)
1.00
1.46 (1.02—2.10)
2.06 (0.93—4.58)
3.46 (1.43—8.40)
1.00
2.03 (0.97—4.28)
2.63 (1.38—4.99)
5.84 (2.53—13.5)
Table 2. ORs of SLFG for FVC, FEV1 and FEF25—75% by the categories
of asthma-like symptoms (adjusted in multiple logistic model
to gender, height and lung function at baseline survey, and
body growth rate in the follow-up).
Variable
Asthma-like symptoms
No
symptoms
N=872
New
symptoms
N=45
Remission
symptoms
N=54
Continued
symptoms
N=30
Gender: 
boys
girls
Parental education: 
low
middle + high
1995
Height (cm) mean
SE
Weight (kg) mean
SE
FVC (L) mean
SE
FEV1 (L) mean
SE
FEF25-75% mean
(L/sec) SE
FEV1/FVC (%)mean
SE
1997-95
DHeight (cm) mean
SE
DWeight (kg) mean
SE
DFVC (L) mean
SE
DFEV1 (L) mean
SE
DFEF25-75% mean
(L/sec) SE
51.1%
48.9%
25.9%
74.1%
133.58
0.20
29.94
0.19
1.955
0.012
1.791
0.011
2.242
0.017
91.82
0.162
11.48
0.11
7.85
0.12 
0.503
0.010
0.416
0.009
0.467
0.015
48.9%
51.1%
31.1%
68.9%
134.67
0.90
31.89
1.07 
1.938
0.060
1.762
0.052
2.200
0.076
91.27
0.805
11.44
0.55
8.09
0.50 
0.523
0.044
0.414
0.041
0.413
0.063
57.4%
42.6%
20.4%
79.6%
135.15
0.83
30.76
0.73
2.036
0.045
1.830
0.041
2.162
0.065
90.05
0.874
11.20
0.47
7.89
0.44
0.439
0.035
0.349
0.033
0.420
0.060
63.3%
36.7%
33.3% 
66.7%
135.07
0.90
31.20
1.06
2.059
0.085
1.851
0.071
2.190
0.105
90.35
1.095
10.90
0.52
9.27
0.73
0.438
0.061
0.302
0.049
0.287
0.070
Table 1. Characterics of the study sample by the occurrence of
asthma like symptoms over the follow-up (1995-97).
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toms. The odds ratios (OR) of SLFG(FVC),
SLFG(FEV1) and SLFG(FEF25-75%) by the occurren-
ce of asthma-like syndrome have been assessed
using the multiple logistic regression model where
the effects in terms of slower lung function growth
have been adjusted to gender, baseline height, ba-
seline lung function and height velocity of children
over the follow-up (table 2).
Adjusted OR for SLFG(FVC) was significantly higher
only in the children having the continued symp-
toms(OR=3.40; 95%CI: 1.32—8.77). There was
a consistent trend of adjusted ORs for SLFG(FEV1)
with the category of symptoms, where OR was
1.46 (95%CI: 1.02 — 2.10) in children with recent
new symptoms; 2.06 (95%CI: 0.93—4.58) in those
with symptoms remitted, while 3.46 (95%CI: 1.43
— 8.40) in children who had persistent symptoms.
The corresponding ORs for SLFG(FEF25-75%) were
2.03 (95%CI: 0.97—4.28), 2.63 (95% CI:
1.38—4.99), and 5.84 (95%CI: 2.53—13.50).
The table 3 documents that the trend in ORs for
obstructive syndrome (FEV1/FVC%£80%) at the
end of the survey (1997) by the category of asth-
matic symptoms is very similar to that observed for
FEV1 and FEF25-75%. Figure 1 summarises the ef-
fect of asthmatic symptoms on the lung growth in
the sample under study.
DISCUSSION
The study has shown lower lung function gain over
the follow up in preadolescent children with asth-
matic symptoms. The risk of the slower lung func-
tion growth (SLFG) in children did not result from
the altered body growth since in addition to gen-
der the effect was adjusted to potential confoun-
ders such as baseline lung function, baseline height
and growth velocity over the follow-up.
The slower lung function growth has been associa-
ted in the strongest way with the persistent asthma-
tic symptoms. Children among whom the symp-
toms had remitted over the last two years showed
significantly better FVC and FEV1 gain than those
with persistent symptoms. This may indicate a ten-
dency for re-acceleration of lung function growth
after remission of symptoms. However, the recove-
ry process in terms of the lung function improve-
ment probably has to take a longer time as chil-
dren with symptoms remitted were still at the lo-
wer end of the FEF25-75% population distribution
for non-symptomatic children.
There are speculations on the nature of the slower
lung function development in asthmatic children.
There is a controversial hypothesis that the asthma-
tic children may loss elastic recoil of the lung
[20,21]. However, some authors suggest that disor-
ders of growth in children suffering from asthma
are rather related with either increased resting
energy expenditure or inadequate energy intake
[22].
The results of this study is in agreement with the
prospective study carried out by Borsboom et al. in
the Dutch children aged 12.5 to 18 yr with or wi-
thout a positive history of prepubertal respiratory
symptoms [23]. The authors showed that adole-
scents with a positive history of prepubertal respi-
ratory symptoms, even if they lose their symptoms,
remain at a disadvantage with respect to their ven-
tilatory function when they reach adulthood.
Unfortunately, the authors did not specify the re-
spiratory symptoms. Observations of Kelly et al.
[24] are also in agreement with our study. They
showed that lung function of young adults (at the
age of 28 years) who had wheezing of variable fre-
quency as children but ceased wheezing was es-
Predictors
FEV1/FVC(%)
£80% >80%
N
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Without symptoms
New symptoms
Remitted symptoms
Continued symptoms
29
4
7
6
843
41
47
24
1.00
2.84 (0.80-9.01)
4.33 (1.63-11.0)
7.27 (2.45-20.6)
1.00
2.99 (0.98-9.08)
4.19 (1.71-10.3)
6.47 (2.38-17.5)
Table 3. ORs of the lung obstructive syndrome (FEV1/FVC£80% in
1997) in children by the occurrence of asthma-like symptoms
over the follow-up.(Adjusted in the multiple logistic model to
gender and parental education).
FVC FEV1 FEF25-75%
0
10
20
30
40
50
60
Asthma-like symptoms:
  No symptoms
  New symptoms
  Remitted symptoms
  Continued symptoms
%
19.3 20.3 20.4
40.0
20.2
26.7
29.6
40.0
19.7
28.9
33.3
50.0
Figure 1. Prevalence of slow lung function growth for FVC, FEV1 and
FEF25-75% by asthma-like symptoms.
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sentially normal, but lung function was increasingly
abnormal in those who continued to wheeze. In
the latter study it was evident that airways obstruc-
tion became more common as wheezing incre-
ased, however, the authors could find no evidence
of decline in lung function related to bronchial re-
activity.
It is difficult to explain the differential rate of rega-
ining normal lung function growth in terms of
FEF25-75% after the remission of asthmatic symp-
toms. As most of asthmatic children are atopic, one
can assume that in atopic children, despite the re-
mission of symptoms, the bronchial inflammation
process may be sustained over certain period of ti-
me. Clinical and cross-sectional studies confirmed
the importance of atopy for lung function level.
This was also confirmed by Sherill et al. [6] in a 6-
-year follow-up study of preadolescent children
where atopy was associated with decreased the
FEV1/FVC ratio and appeared to be independent
of clinical symptoms and airway responsiveness. In
other studies, the degree of bronchial responsive-
ness correlated with the development of lung func-
tion [25]. However, neither bronchial responsive-
ness nor markers of bronchial inflammation were
measured in our study.
The consistent association between degree of re-
versibility of asthma-like symptoms and lung func-
tion gain in preadolescent children confirmed the
significance of the asthma-like symptoms in the na-
tural history of ventilatory function. So it seems ju-
stified that even children with occasional and re-
cent wheezing, should be classified as belonging to
the asthmatic risk group with all implications both
to the individuals and in terms of the quality of the
epidemiological data used to establish the true pre-
valence of asthma. The observed slower lung func-
tion gain in preadolescence may have implications
for the development of chronic lung disease later
in adulthood and this has been suggested previo-
usly by many observations. The children with the
slower lung function may eventually be more su-
sceptible to environmental insults and be at an in-
creased risk for the development of accelerated
decline in FEV1 later in life [26—28]. However, only
the prolonged longitudinal measurements of lung
function performed in subsequent years would
show whether the airway function of the sympto-
matic children catch up lung growth and attain
a level comparable with the general population.
CONCLUSIONS
1. The consistent association between reversibility
of asthma-like symptoms and lung function gain
in preadolescent children confirmed the clinical
significance of the symptoms in the natural hi-
story of ventilatory function.
2. The observed slower lung function gain in pre-
adolescence may have implications for the de-
velopment of chronic lung disease later in adul-
thood. The children with the slower lung func-
tion may be more susceptible to environmental
insults and be at an increased risk for the deve-
lopment of accelerated decline in FEV1 later in
life.
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